• Home
  • A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia.

A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia.

Author List
Redner RL, Beumer JH, Kropf P, Agha M, Boyiadzis M, Dorritie K, Farah R, Hou JZ, Im A, Lim SH, Raptis A, Sehgal A, Christner SM, Normolle D, Johnson DE
Publication
Leukemia & lymphoma
Publication ID (Profile URL)
https://researcherprofiles.org/profile/141772099
Publication Year
2018
PubMed ID
29616864
Publication Title
Redner RL, Beumer JH, Kropf P, Agha M, Boyiadzis M, Dorritie K, Farah R, Hou JZ, Im A, Lim SH, Raptis A, Sehgal A, Christner SM, Normolle D, Johnson DE. A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia. Leuk Lymphoma. 2018 11; 59(11):2595-2601.